Imaging Technology

AUGUST 28, 2023

milla1cf Mon, 08/28/2023 - 13:57 August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that they have signed a strategic collaboration to increase the global availability of actinium-225 (225Ac), a radioisotope that has the potential to treat a large variety of cancer indications.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Medical Clinic 98

Imaging Technology

JANUARY 12, 2024

Other technologies use anatomical images to guide radiotherapy delivery; however, SCINTIX therapy is the only radiotherapy to use emissions from cancer cells, created by injecting the patient with a radiopharmaceutical, to deliver a radiation dose that continuously and autonomously targets the cancer itself.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Medicare Clinic 105

AuntMinnie

FEBRUARY 12, 2024

Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University.

PET Scan 104

PET Scan Diagnose Disease Radiopharmaceuticals 104

Imaging Technology

JANUARY 23, 2024

Acceptance testing was completed in December 2023, with the cyclotron reaching full beam power (750µA) at full energy. This 70 MeV cyclotron will be dedicated to the production of next-generation medical isotopes used mainly in the diagnosis of critical illnesses.

Radiopharmaceuticals 111

Radiopharmaceuticals Disease Diagnostic Clinic 111

AuntMinnie

OCTOBER 2, 2024

Ultrasound model predicts liver disease progression. Horowitz, et al, Medical Hypotheses , October 13, 2023. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion. Plesner, et al, Radiology , September 26, 2023. SPECT/CT reveals heart’s response to tafamidis.

Digital Imaging and Communications in Medicine 137

Digital Imaging and Communications in Medicine X-ray MRI Hospital 137

Imaging Technology

MAY 30, 2023

milla1cf Tue, 05/30/2023 - 19:49 May 30, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals , today announced U.S. manufacturer and distributor, PETNET Solutions Inc, A Siemens Healthineers Company.

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97

Imaging Technology

JUNE 26, 2023

Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. For more information: www.snmmi.org Find more SNMMI23 conference coverage here Monday, June 26, 2023 - 19:43

Nuclear Medicine 98

Nuclear Medicine Education Radiopharmaceuticals Hospital 98

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JANUARY 30, 2024

The timing of the new codes dovetails with advances in neuroimaging, such as in the assessment of white-matter diseases. FLAIR WMH may have specific risk factors and pathologic underpinnings in [repetitive head impact] RHI-exposed individuals," Alosco's team concluded in their article published in December 2023 in Neurology.

MRI 105

MRI Radiopharmaceuticals Disease Imaging 105

Imaging Technology

SEPTEMBER 27, 2023

from October 1 to 4, 2023. from October 1 to 4, 2023. Details of selected oral and poster presentations by Blue Earth Diagnostics and its collaborators are listed below. HIGHLIGHTED SCIENTIFIC PRESENTATIONS Monday, October 2, 2023 Oral presentation Title: Detection Rate of 18F-rhPSMA-7.3 Gauden , D.Phil.,

Diagnostic 105

Diagnostic Radiation Oncology Radiation Clinic 105

Imaging Technology

JULY 28, 2023

Food and Drug Administration (FDA) on May 25, 2023. Food and Drug Administration approval for its radiohybrid PET diagnostic imaging product for use in prostate cancer in 2023. POSLUMA was approved by the U.S. It is the first and only FDA-approved, PSMA-targeted imaging agent developed with proprietary radiohybrid (rh) technology.

Diagnostic 98

Diagnostic Clinic Radiopharmaceuticals Radiation 98

Imaging Technology

JULY 20, 2023

milla1cf Thu, 07/20/2023 - 20:11 July 20, 2023 — The members of the American Society for Radiation Oncology ( ASTRO ) recently elected three new officers to ASTRO’s Board of Directors, including Sameer Keole , MD, FASTRO , as President-elect; Wendy Woodward , MD, PhD, FASTRO, as Science Council Vice Chair; and Vivek S.

Radiation Oncology 98

Radiation Oncology Radiation Government Community Practice 98

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

OCTOBER 5, 2023

Effective initial staging of prostate cancer, particularly with regards to the detection of metastatic disease, is critical to optimal clinical management of patients,” said Phillip H. Such information can help guide treatment selection and potentially avoid futile surgery for patients with high-risk disease.” “We

Diagnose 52

Diagnose Diagnostic Disease Radiation 52

Imaging Technology

MAY 23, 2023

milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). in the past three decades.

Radiation Oncology 96

Radiation Oncology Radiation Clinic Medicare 96

Imaging Technology

JULY 25, 2023

milla1cf Tue, 07/25/2023 - 20:22 July 25, 2023 — Ratio Therapeutics Inc. By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. FAP is a membrane-bound dipeptidyl peptidase that is specifically expressed in activated fibroblasts.

Radiopharmaceuticals 98

Radiopharmaceuticals Imaging Pharmaceutical Disease 98

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. How many centers have the physical space in their nuclear medicine departments to treat a disease as common as prostate cancer?" However, few freestanding theranostics centers exist today. Morris continued in the JNM.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

Imaging Technology

JULY 11, 2023

milla1cf Tue, 07/11/2023 - 09:02 July 11, 2023 — Ratio Therapeutics Inc. By leveraging our expertise in radiopharmaceuticals, we aim to contribute to the early detection and accurate monitoring of epithelial-derived cancers. FAP is a membrane-bound dipeptidyl peptidase that is specifically expressed in activated fibroblasts.

Radiopharmaceuticals 75

Radiopharmaceuticals Imaging Pharmaceutical Disease 75

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease 52

Disease Medicare Imaging PET Scan 52

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 98

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 98

Imaging Technology

MAY 2, 2023

milla1cf Tue, 05/02/2023 - 23:50 May 2, 2023 — Blue Earth Diagnostics , a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced additional results from its completed Phase 3 SPOTLIGHT trial of 18F-rhPSMA-7.3 18F-rhPSMA-7.3 Gauden , D.Phil.,

Diagnostic 98

Diagnostic Radiopharmaceuticals Imaging Radiation 98